PGD helps to improve the implantation rate and thus, reduce pregnancy losses especially for women over 35 years of age and for women who have had miscarriages.
Pre - implantation Genetic Diagnosis - (PGD) helps to identify certain genetic defects in embryos that are created during in-vitro fertilization. Thanks to this test, it is possible to avoid passing on some disorders or diseases to the baby. After collecting and fertilizing an egg, we will extract some cells when the embryo has begun to develop. These cells are examined in order to detect the presence of genes that might be problematic.
If the embryo is free from any genetic defects, it is placed in the uterus so that it can be implanted. Any additional embryo that has no genetic defects can be frozen for its further use. Meanwhile, the ones that show genetic defects will be destroyed.
This way of analyzing the embryos beforehand helps to improve the implantation rate and thus, reduce pregnancy losses. This technique has been very helpful to women over 35 and to women who have had some miscarriages.
MOMSOON has partnered with Genetic Testing laboratories
Known for technology based solutions in reproductive testing that enable us to deliver the best outcomes. We offer the most accurate Non-Invasive Prenatal Screening Test (NIPT) , Genetic Carrier Screening Test , and Pre-implantation Genetic Screening / Diagnosis (PGS/PGD).MedGenome is driven to enable clinicians to deliver the best outcomes to their patients. Their passion to deliver actionable insights to clinicians has resulted in the development of ‘Claria’ – a suite of NGS (Next-generation Sequencing) technology-based solutions for reproductive testing. Claria offers the most accurate Non-Invasive Prenatal Screening Test (NIPT), Genetic Carrier Screening Test, and Preimplantation Genetic Screening/Diagnosis (PGS/PGD). In addition to this, Claria also offers routine prenatal diagnostics, and cytogenetic tests.
FREE GENETIC COUNSELLING